Suppr超能文献

1990年至2021年全球、区域和国家层面糖尿病肾病的流行病学研究:基于2021年全球疾病负担研究的分析

Epidemiological research on diabetic nephropathy at global, regional, and national levels from 1990 to 2021: an analysis derived from the global burden of disease 2021 study.

作者信息

Zhang Lu, Jiang Liangliang, Xu Rong, Zhang Xuemei, Zhang Boxun, Yue Rensong

机构信息

Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

出版信息

Front Endocrinol (Lausanne). 2025 Aug 27;16:1647064. doi: 10.3389/fendo.2025.1647064. eCollection 2025.

Abstract

OBJECTIVE

A comprehensive assessment of the disease burden is essential for developing effective strategies to address diabetic nephropathy. This study investigates the long-term global trends and epidemiological characteristics of diabetic nephropathy.

METHODS

Data on diabetic nephropathy from the Global Burden of Disease (GBD) 2021 were utilized to evaluate morbidity, mortality, disability-adjusted life years (DALYs), and the impact of the Socio-Demographic Index (SDI). Global risk attribution was assessed, and the Bayesian Age-Period-Cohort (BAPC) model was applied to forecast the future burden of diabetic nephropathy.

RESULTS

In 2021, there were 107.6 million prevalent cases of diabetic nephropathy globally (95% UI: 99.2-116.0), with an age-standardized prevalence rate of 1,259.6 per 100,000 population (95% UI: 1,162.0-1,359.9), representing a 5.1% decline since 1990. Global deaths attributed to diabetic nephropathy in 2021 reached 477.3 thousand (95% UI: 401.5-566.0), with an age-standardized mortality rate of 5.7 per 100,000 (95% UI: 4.8-6.8), reflecting a 37.8% increase since 1990. The number of DALYs attributable to diabetic nephropathy was 11,278.9 thousand (95% UI: 9,682.8-13,103.9), with an age-standardized DALY rate of 131.1 per 100,000 (95% UI: 112.8-152.5), indicating a 24% rise since 1990.

CONCLUSIONS

Over the past three decades, the global age-standardized prevalence of diabetic nephropathy has declined, while age-standardized mortality and DALY rates have increased. Significant disparities exist in prevalence, incidence, and DALY rates across regions and countries. The SDI exerts a notable influence on diabetic nephropathy prevalence, underscoring the importance of sustained and enhanced management of risk factors to prevent and treat this condition. Diabetic nephropathy remains a critical global health challenge moving forward.

摘要

目的

全面评估疾病负担对于制定应对糖尿病肾病的有效策略至关重要。本研究调查糖尿病肾病的长期全球趋势和流行病学特征。

方法

利用全球疾病负担(GBD)2021中关于糖尿病肾病的数据来评估发病率、死亡率、伤残调整生命年(DALYs)以及社会人口指数(SDI)的影响。评估全球风险归因,并应用贝叶斯年龄-时期-队列(BAPC)模型预测糖尿病肾病未来的负担。

结果

2021年,全球糖尿病肾病的患病率为1.076亿例(95%不确定区间:9920万 - 1.16亿),年龄标准化患病率为每10万人1259.6例(95%不确定区间:1162.0 - 1359.9),自1990年以来下降了5.1%。2021年全球归因于糖尿病肾病的死亡人数达47.73万(95%不确定区间:40.15万 - 56.6万),年龄标准化死亡率为每10万人5.7例(95%不确定区间:4.8 - 6.8),自1990年以来增加了37.8%。归因于糖尿病肾病的伤残调整生命年数为1127.89万(95%不确定区间:968.28万 - 1310.39万),年龄标准化伤残调整生命年率为每10万人131.1例(95%不确定区间:112.8 - 152.5),自1990年以来上升了24%。

结论

在过去三十年中,全球糖尿病肾病的年龄标准化患病率下降,而年龄标准化死亡率和伤残调整生命年率上升。各地区和国家在患病率、发病率和伤残调整生命年率方面存在显著差异。社会人口指数对糖尿病肾病患病率有显著影响,凸显了持续加强危险因素管理以预防和治疗该病的重要性。糖尿病肾病仍是未来一项严峻的全球健康挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7638/12420290/5b4520e8717e/fendo-16-1647064-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验